This inventor holds 2 USPTO granted patents. Top assignee: Renovis, Inc.. Active years: 2007-2008.
Company Filing History:
Years Active: 2007-2008
Title: David Lonergan: Innovator in Pharmaceutical Chemistry
Introduction
David Lonergan is a notable inventor based in Sunnyvale, CA. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on ion channel ligands. With a total of 2 patents, Lonergan's research focuses on developing compounds that can be utilized in the treatment of various medical conditions.
Latest Patents
Lonergan's latest patents include the development of bicycloheteroarylamine compounds as ion channel ligands. These amine compounds are designed to be prepared as pharmaceutical compositions. They may be used for the prevention and treatment of a variety of conditions in mammals, including humans. Some of the conditions addressed by these compounds include pain, inflammation, and traumatic injury.
Career Highlights
David Lonergan is currently associated with Renovis, Inc., where he continues to advance his research in pharmaceutical applications. His work has been instrumental in exploring new therapeutic avenues for treating complex medical issues.
Collaborations
Throughout his career, Lonergan has collaborated with esteemed colleagues such as Guoxian Wu and Michael G Kelly. These partnerships have fostered a collaborative environment that enhances the innovation process.
Conclusion
David Lonergan stands out as a key figure in the realm of pharmaceutical innovation. His contributions through patents and collaborative efforts continue to impact the field positively.